Orchestra BioMed (Nasdaq:OBIO) today announced the pricing of an underwritten public offering totaling proceeds of ...

Carlsmed (Nasdaq:CARL) today announced new technology add-on payment (NTAP) reimbursement for its spine implant technology.

Ultromics announced that it raised $55 million in a Series C financing to support its AI-powered heart failure diagnostic ...

Boston Scientific (NYSE: BSX) announced today that CMS granted reimbursement for its Agent drug-coated balloon (DCB).